dihexa solubility ph dependent Molecules of the Month – February 2026 DHX / PNB-0408 - Pure

FDA reviewers, applying the statutory framework under 21 CFR 216.23(c), identified only one human study for BPC-157's proposed indication of ulcerative colitis: a decades-old meeting abstract that was never published as a peer-reviewed trial and that used an oral route of administration not the injectable or subcutaneous routes that wellness clinics commonly use

Oncology (Blincyto, Lumakras, Kyprolis)

Overall, peptide-based cancer vaccines fail to reach high efficacy levels when used alone, but they show promise when used in combination with other treatments

10.1128/MMBR.53.4.450-490.1989

Each tablet contains 500mcg of BPC-157, and the product is manufactured specifically for research use only